Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Provention Bio, Inc. (PRVB) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Provention Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1695357.
Total stock buying since 2018: $5,381,197.
Total stock sales since 2018: $85,677,225.
Total stock option exercises since 2018: $1,100,140.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 5,395,049 | $83,545,345 | 200,000 | $499,998 |
| 2022 | 0 | $0 | 199,617 | $2,044,791 | 199,617 | $499,042 |
| 2021 | 14,501 | $98,941 | 0 | $0 | 0 | $0 |
| 2020 | 28,349 | $266,361 | 0 | $0 | 32,246 | $76,100 |
| 2019 | 122,625 | $1,177,800 | 7,300 | $87,089 | 0 | $0 |
| 2018 | 1,018,287 | $3,838,095 | 0 | $0 | 10,000 | $25,000 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-04 | 0 | $0 | 2,190,549 | $53,274,151 | 0 | $0 |
| 2023-02 | 0 | $0 | 156,320 | $1,576,555 | 151,820 | $379,549 |
| 2023-01 | 0 | $0 | 3,048,180 | $28,694,639 | 48,180 | $120,449 |
| 2022-12 | 0 | $0 | 199,617 | $2,044,791 | 199,617 | $499,042 |
| 2021-12 | 5,201 | $33,764 | 0 | $0 | 0 | $0 |
| 2021-11 | 9,300 | $65,177 | 0 | $0 | 0 | $0 |
| 2020-09 | 2,299 | $27,045 | 0 | $0 | 0 | $0 |
| 2020-08 | 9,550 | $124,819 | 0 | $0 | 0 | $0 |
| 2020-06 | 2,000 | $30,862 | 0 | $0 | 0 | $0 |
| 2020-04 | 0 | $0 | 0 | $0 | 32,246 | $76,100 |
| 2020-03 | 14,500 | $83,635 | 0 | $0 | 0 | $0 |
| 2019-12 | 6,075 | $76,154 | 0 | $0 | 0 | $0 |
| 2019-09 | 44,450 | $325,311 | 0 | $0 | 0 | $0 |
| 2019-08 | 23,100 | $210,615 | 0 | $0 | 0 | $0 |
| 2019-06 | 49,000 | $565,720 | 7,300 | $87,089 | 0 | $0 |
| 2018-12 | 89,537 | $168,243 | 0 | $0 | 0 | $0 |
| 2018-11 | 35,000 | $94,852 | 0 | $0 | 10,000 | $25,000 |
| 2018-07 | 893,750 | $3,575,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-14 | Petry John (10% Owner) | Sale | 2,190,549 | 24.32 | 53,274,151 |
| 2023-02-13 | Leon Francisco (Chief Scientific Officer) | Sale | 25,985 | 10.04 | 260,941 |
| 2023-02-13 | Leon Francisco (Chief Scientific Officer) | Option Ex | 25,985 | 2.50 | 64,962 |
| 2023-02-13 | Palmer Ashleigh (Director and CEO) | Sale | 25,835 | 10.04 | 259,460 |
| 2023-02-13 | Palmer Ashleigh (Director and CEO) | Option Ex | 25,835 | 2.50 | 64,587 |
| 2023-02-10 | Hoitt Jason (Chief Commercial Officer) | Sale | 4,500 | 10.00 | 45,004 |
| 2023-02-10 | Leon Francisco (Chief Scientific Officer) | Sale | 50,000 | 10.11 | 505,600 |
| 2023-02-10 | Leon Francisco (Chief Scientific Officer) | Option Ex | 50,000 | 2.50 | 125,000 |
| 2023-02-10 | Palmer Ashleigh (Director and CEO) | Sale | 50,000 | 10.11 | 505,550 |
| 2023-02-10 | Palmer Ashleigh (Director and CEO) | Option Ex | 50,000 | 2.50 | 125,000 |
| 2023-01-18 | Leon Francisco (Chief Scientific Officer) | Sale | 24,015 | 10.27 | 246,586 |
| 2023-01-18 | Leon Francisco (Chief Scientific Officer) | Option Ex | 24,015 | 2.50 | 60,037 |
| 2023-01-18 | Petry John (10% Owner) | Sale | 3,000,000 | 9.40 | 28,200,000 |
| 2023-01-18 | Palmer Ashleigh (Director and CEO) | Sale | 24,165 | 10.27 | 248,053 |
| 2023-01-18 | Palmer Ashleigh (Director and CEO) | Option Ex | 24,165 | 2.50 | 60,412 |
| 2022-12-29 | Leon Francisco (Chief Scientific Officer) | Sale | 187,000 | 10.26 | 1,918,620 |
| 2022-12-29 | Leon Francisco (Chief Scientific Officer) | Option Ex | 187,000 | 2.50 | 467,500 |
| 2022-12-27 | Leon Francisco (Chief Scientific Officer) | Sale | 10,674 | 10.00 | 106,740 |
| 2022-12-27 | Leon Francisco (Chief Scientific Officer) | Option Ex | 10,674 | 2.50 | 26,685 |
| 2022-12-23 | Leon Francisco (Chief Scientific Officer) | Sale | 375 | 10.00 | 3,750 |
| 2022-12-23 | Leon Francisco (Chief Scientific Officer) | Option Ex | 375 | 2.50 | 937 |
| 2022-12-22 | Leon Francisco (Chief Scientific Officer) | Sale | 1,568 | 10.00 | 15,681 |
| 2022-12-22 | Leon Francisco (Chief Scientific Officer) | Option Ex | 1,568 | 2.50 | 3,920 |
| 2021-12-03 | Ramos Eleanor (Chief Medical Officer) | Buy | 5,201 | 6.49 | 33,764 |
| 2021-11-30 | Palmer Ashleigh (Director and CEO) | Buy | 3,750 | 6.66 | 24,990 |
| 2021-11-24 | Leon Francisco (Chief Scientific Officer) | Buy | 5,550 | 7.24 | 40,187 |
| 2020-09-02 | Ramos Eleanor (Chief Medical Officer) | Buy | 299 | 12.06 | 3,605 |
| 2020-09-02 | Drechsler Andrew T (Chief Financial Officer) | Buy | 2,000 | 11.72 | 23,440 |
| 2020-08-21 | Leon Francisco (Chief Scientific Officer) | Buy | 2,000 | 13.35 | 26,708 |
| 2020-08-20 | Ramos Eleanor (Chief Medical Officer) | Buy | 2,500 | 13.23 | 33,075 |
| 2020-08-18 | Palmer Ashleigh (President and CEO) | Buy | 500 | 12.69 | 6,345 |
| 2020-08-17 | Palmer Ashleigh (President and CEO) | Buy | 2,800 | 12.83 | 35,924 |
| 2020-08-13 | Drechsler Andrew T (Chief Financial Officer) | Buy | 1,750 | 13.01 | 22,767 |
| 2020-06-24 | Leon Francisco (Chief Scientific Officer) | Buy | 2,000 | 15.43 | 30,862 |
| 2020-04-10 | Bluestone Jeffrey | Option Ex | 32,246 | 2.36 | 76,100 |
| 2020-03-19 | Hoitt Jason (Chief Commercial Officer) | Buy | 4,500 | 5.43 | 24,435 |
| 2020-03-19 | Leon Francisco (Chief Scientific Officer) | Buy | 10,000 | 5.92 | 59,200 |
| 2019-12-26 | Ramos Eleanor (CMO & COO) | Buy | 2,000 | 14.34 | 28,680 |
| 2019-12-20 | Palmer Ashleigh (President and CEO) | Buy | 2,075 | 11.39 | 23,634 |
| 2019-12-16 | Leon Francisco (Chief Scientific Officer) | Buy | 2,000 | 11.92 | 23,840 |
| 2019-09-30 | Leon Francisco (Chief Scientific Officer) | Buy | 1,450 | 7.67 | 11,121 |
| 2019-09-30 | Digiandomenico Anthony | Buy | 30,000 | 6.83 | 204,900 |
| 2019-09-26 | Digiandomenico Anthony | Buy | 5,000 | 8.44 | 42,200 |
| 2019-09-25 | Digiandomenico Anthony | Buy | 5,000 | 8.39 | 41,950 |
| 2019-09-24 | Palmer Ashleigh (President and CEO) | Buy | 3,000 | 8.38 | 25,140 |
| 2019-08-08 | Leon Francisco (Chief Scientific Officer) | Buy | 2,500 | 9.09 | 22,725 |
| 2019-08-08 | Palmer Ashleigh (President and CEO) | Buy | 10,600 | 9.15 | 96,990 |
| 2019-08-08 | Digiandomenico Anthony | Buy | 10,000 | 9.09 | 90,900 |
| 2019-06-20 | Digiandomenico Anthony | Buy | 10,000 | 10.96 | 109,600 |
| 2019-06-18 | Palmer Ashleigh (President and CEO) | Buy | 4,000 | 10.83 | 43,320 |
| 2019-06-18 | Digiandomenico Anthony | Buy | 10,000 | 10.88 | 108,800 |
| 2019-06-17 | Bluestone Jeffrey | Sale | 7,300 | 11.93 | 87,089 |
| 2019-06-17 | Digiandomenico Anthony | Buy | 25,000 | 12.16 | 304,000 |
| 2018-12-31 | Leon Francisco (Chief Scientific Officer) | Buy | 10,000 | 1.64 | 16,400 |
| 2018-12-31 | Palmer Ashleigh (President and CEO) | Buy | 825 | 1.58 | 1,303 |
| 2018-12-28 | Pisano Wayne | Buy | 5,000 | 1.80 | 9,000 |
| 2018-12-28 | Palmer Ashleigh (President and CEO) | Buy | 5,000 | 1.73 | 8,650 |
| 2018-12-28 | Digiandomenico Anthony | Buy | 10,000 | 1.76 | 17,600 |
| 2018-12-27 | Digiandomenico Anthony | Buy | 20,000 | 1.95 | 39,000 |
| 2018-12-26 | Catlin Avery W | Buy | 5,000 | 1.85 | 9,250 |
| 2018-12-24 | Catlin Avery W | Buy | 5,000 | 1.90 | 9,500 |
| 2018-12-24 | Digiandomenico Anthony | Buy | 17,270 | 1.92 | 33,158 |
| 2018-12-21 | Digiandomenico Anthony | Buy | 2,000 | 1.85 | 3,700 |
| 2018-12-20 | Digiandomenico Anthony | Buy | 5,000 | 1.96 | 9,800 |
| 2018-12-03 | Digiandomenico Anthony | Buy | 4,442 | 2.45 | 10,882 |
| 2018-11-30 | Digiandomenico Anthony | Buy | 4,849 | 2.45 | 11,880 |
| 2018-11-29 | Digiandomenico Anthony | Buy | 151 | 2.47 | 372 |
| 2018-11-27 | Digiandomenico Anthony | Buy | 10,000 | 2.46 | 24,600 |
| 2018-11-26 | Digiandomenico Anthony | Buy | 10,000 | 2.65 | 26,500 |
| 2018-11-13 | Drechsler Andrew T (Chief Financial Officer) | Option Ex | 10,000 | 2.50 | 25,000 |
| 2018-11-09 | Catlin Avery W | Buy | 10,000 | 3.15 | 31,500 |
| 2018-07-19 | Pisano Wayne | Buy | 2,500 | 4.00 | 10,000 |
| 2018-07-19 | Leon Francisco (Chief Scientific Officer) | Buy | 37,500 | 4.00 | 150,000 |
| 2018-07-19 | Palmer Ashleigh (President and CEO) | Buy | 37,500 | 4.00 | 150,000 |
| 2018-07-19 | Ramos Eleanor (Chief Medical Officer & COO) | Buy | 60,000 | 4.00 | 240,000 |
| 2018-07-19 | Drechsler Andrew T (Chief Financial Officer) | Buy | 6,250 | 4.00 | 25,000 |
| 2018-07-19 | Appel Peter A | Buy | 750,000 | 4.00 | 3,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of PRVB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Provention Bio, Inc. (symbol PRVB, CIK number 1695357) see the Securities and Exchange Commission (SEC) website.